Adam Feuerstein articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/11/24 12:22
2014/11/24 12:22
1d
The deal is a gamble of sorts for Biomarin, which is betting that its experience and expertise in securing approvals for so-called "orphan disease" drugs can help Prosensa win approval for...
2014/11/24 12:22
2014/11/24 12:22
Latest videos
2014/11/21 11:22
2014/11/21 11:22
4d
BOSTON ( TheStreet) -- Washington Post business columnist Steven Pearlstein accused me -- falsely -- of working with short-selling hedge funds to manipulate stock prices and force small biotech...
2014/11/21 11:22
2014/11/21 11:22
4d
Cognate BioServices, the privately held manufacturing services company majority owned by Northwest CEO Linda Powers, continues to benefit from its ties to Northwest. In the third quarter, Northwest...
2014/11/19 15:22
2014/11/19 15:22
6d
BOULDER, Col. ( TheStreet) -- Clovis Oncology(CLVS) and AstraZeneca(AZN) are locked in a tight and very competitive race to develop two similar, targeted lung cancer drugs. Healthcare investors are...
2014/11/18 23:22
2014/11/18 23:22
7d
CAMBRIDGE, Mass. (TheStreet) -- A second experimental drug from Agios Pharmaceuticals(AGIO) designed to attack the "metabolism" of cancer cells has demonstrated early but strong clinical responses in...
2014/11/15 15:22
2014/11/15 15:22
10d
PHILADELPHIA ( TheStreet) -- Fabry disease patients treated with Amicus Therapeutics'(FOLD) experimental pill migalastat exhibited improvements in the size of their hearts and fewer disease-related...
2014/11/14 21:22
2014/11/14 21:22
11d
HAMPTON, NJ (TheStreet) -- Treatment with an experimental, targeted immunotherapy developed by Celldex Therapeutics(CLDX) added to Roche's(RHHBY) Avastin is delaying tumor growth and extending...
2014/11/12 10:22
2014/11/12 10:22
13d
Those results included the "hardest-to-treat" patients no longer responding to platinum-based chemotherapy. That's the good news. The bad news is the study doesn't yield enough data to make a...
2014/11/10 12:22
2014/11/10 12:22
15d
The beleaguered prostate cancer vaccine company filed for voluntary federal bankruptcy protection Monday and reached an agreement with holders of $620 million in convertible debt in which the...
2014/11/10 05:22
2014/11/10 05:22
15d
CAMBRIDGE, Mass. ( THESTREET) -- Certain patients have epilepsy so severe that current drugs can't stop the brain from suffering seizures. The only way to treat these patients is to place them in a...
2014/11/10 00:22
2014/11/10 00:22
16d
A triple therapy combining two experimental Merck drugs with Gilead's Sovaldi yielded interim hepatitis C cure rates for genotype 1 patients ranging from 80% to 87% following six to eight weeks of...
2014/11/07 13:22
2014/11/07 13:22
18d
BOSTON ( TheStreet) -- An FDA advisory panel Thursday evening decided the benefits of Rockwell Medical's(RMTI) iron replacement therapy Triferic outweighed its risks for maintaining iron stores and...
2014/11/06 13:22
2014/11/06 13:22
19d
The acquired drug, Myalept, received U.S. approval in February to treat generalized or acquired lipodystrophy, rare conditions in which patients are either born with too little fat tissue or lose fat...
2014/11/05 13:22
2014/11/05 13:22
20d
On Sept. 29, Seattle Genetics reported the long awaited results from the "AETHERA" study of Adcetris as a "maintenance" treatment for Hodgkin's lymphoma. In the study, Adcetris showed a very robust...
2014/10/30 21:23
2014/10/30 21:23
26d
One hedge fund manager who owns Aegerion believes investors should judge Beer more by his actions as CEO than what he does in his personal life. He asked not to be identified by name and he doesn't...
2014/10/30 21:23
2014/10/30 21:23
26d
Third quarter sales of Juxtapid, Aegerion's cholesterol-lowering drug, were 43.7 million, well off the $49 million consensus expected by the Street. Aegerion cut 2014 revenue guidance to a range of...
2014/10/27 17:22
2014/10/27 17:22
29d
Divorce Suit Names CEOs Involved in Cocaine Use, Extramarital Sex Romps A dirty divorce for one of Wall Street's top bankers just got messier. Sage Kelly is the global head of health care investment...
2014/10/24 13:22
2014/10/24 13:22
m
Stuart A. writes: "Adam, Rockwell Medical has an FDA advisory committee meeting coming up soon. Can you talk about the issues that might be raised there?" The Food and Drug Administration is...
2014/10/23 14:22
2014/10/23 14:22
m
TEL AVIV, Israel ( TheStreet) -- Alcobra(ADHD) disclosed in a regulatory filing Wednesday night new details about the phase III study of attention-deficit hyperactivity disorder drug candidate MDX...
2014/11/24 12:22
2014/11/24 12:22
Latest from Twitter